Medical AI healthcare data specialist MaeinBlock announced successful completion of 2.6 billion won total funding for the year: 500 million won investment + 1.9 billion won R&D policy funds + 200 million won working capital. The investment was secured through 300 million won institutional investment from accelerator Kingsley Ventures and 500 million won development funds via TIPS (Tech Incubator Program for Startups) — officially recognizing the innovation and technology development capability of the healthcare-specialized conversational AI solution. Key 2024 milestones: official unveiling of MediKoGPT at the Korea-Vietnam Economic Cooperation Forum in Hanoi (July), domestic debut at Gangwon's largest medical device exhibition GMES 2024 (September), and announcing Vietnamese and Indonesian language-based AI solution development at the 4th Korea-Vietnam DX Forum in Hanoi (November) — formalizing overseas expansion into Vietnam and Indonesia. MediKoGPT applies RAG and LTM to deliver reliable healthcare knowledge and personalized medical services, with effectiveness verification planned through pilot with Professor Bang Chang-seok's gastroenterology team at Hallym University Chuncheon Sacred Heart Hospital. MaeinBlock plans to exhibit MediKoGPT's gastroenterology version at CES 2025 in January as the global market entry opening, with plans to expand to Southeast Asia, Japan, and Europe. CEO Park Jong-hyeong: "Securing 2.6 billion won in R&D funds is recognition of the potential of AI-based medical solutions in the healthcare market."